No Data
No Data
Tailin Biotech (300813.SZ) plans to pay 1 yuan for 10 shares to be deducted from interest on May 27
Tailin Biotech (300813.SZ) announced that the company's 2023 equity distribution plan: every 10 shares to all shareholders...
Tailin Biotech: The conversion price was adjusted from 16.5 yuan/share to 16.4 yuan/share
Zhejiang Tailin Biotechnology Co., Ltd. announced that the conversion price of “Tailin Biotech” was adjusted from 16.5 yuan/share to 16.4 yuan/share. The effective date of the conversion price adjustment is May 27, 2024.
The concept of cellular immunotherapy fluctuated and declined. Jimin Medical and Nanhua Biotech fell to a standstill, Tailin Biotech fell by more than 8%, and Nanjing Xinbai and Sihuan Biotech followed suit.
The concept of cellular immunotherapy fluctuated and declined. Jimin Medical and Nanhua Biotech fell to a standstill, Tailin Biotech fell by more than 8%, and Nanjing Xinbai and Sihuan Biotech followed suit.
Express News | Tailin Biotech: There have been no major changes in the business situation and internal and external business environment
Tailin Biotech (300813.SZ): The subsidiary has no products in the manufacture of bio-based materials or synthetic materials
Gelonghui, May 9丨Tailin Biology (300813.SZ) said on the investor interactive platform that its subsidiary Tailin Medical Devices currently has no products in the manufacture of bio-based materials or synthetic materials.
Tailin Biotech (300813.SZ): The company has no medical equipment related to autologous stem cell regeneration insulin transplantation
Gelonghui, May 9丨Tailin Biotech (300813.SZ) said on the investor interactive platform that the company has no medical equipment related to autologous stem cell regeneration insulin transplantation.
No Data